Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for methadone toxicity
IRCT20201220049774N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of long-chain triglyceride lipid emulsion and naloxone in methadone intoxication (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Number of breaths per minute. Started Jan 2022; status: completed.
02
Drugs
long-chain triglyceride lipid emulsionnaloxone
03
Conditions
methadone intoxication
Beyond the preview
Go deeper on IRCT20201220049774N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201220049774N2.